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The membrane protein RFT1 is 
essential for normal protein N-glycosylation, 
but its precise function is not known. RFT1 was 
originally proposed to translocate the glycolipid 
Man5GlcNAc2-PP-dolichol (needed to 
synthesize N-glycan precursors) across the 
endoplasmic reticulum membrane, but 
subsequent studies showed that it does not play 
a direct role in transport. In contrast to the 
situation in yeast, RFT1 is not essential for 
growth of the parasitic protozoan Trypanosoma 
brucei, enabling the study of its function in a 
null background. We now report that lack of T. 
brucei RFT1 (TbRFT1) not only affects protein 
N-glycosylation but also 
glycosylphosphatidylinositol (GPI) anchor side 
chain modification. Analysis by 
immunoblotting, metabolic labeling and mass 
spectrometry demonstrated that the major 
GPI-anchored proteins of T. brucei procyclic 
forms have truncated GPI anchor side chains in 
TbRFT1 null parasites compared to wild-type 
cells, a defect that is corrected by expressing a 
tagged copy of TbRFT1 in the null background. 
In vivo and in vitro labeling experiments using 
radiolabeled GPI precursors showed that GPI 
underglycosylation was not the result of 
decreased formation of the GPI precursor lipid 
or defective galactosylation of GPI 
intermediates in the endoplasmic reticulum, but 
rather due to modifications that are expected to 
occur in the Golgi apparatus. Unexpectedly, 
immunofluorescence microscopy localized 
TbRFT1 to both the endoplasmic reticulum and 
the Golgi, consistent with the proposal that 
TbRFT1 plays a direct or indirect role in GPI 
anchor glycosylation in the Golgi apparatus. 
Our results implicate RFT1 in a wider range of 
glycosylation processes than previously 
appreciated. 
 
Trypanosoma brucei is a human and 
animal parasite endemic in sub-Saharan Africa 
causing sleeping sickness in humans and nagana in 
livestock. The life cycle of the extracellular living 
parasite comprises stages in the midgut and 
salivary gland of the tsetse fly vector and in the 
blood of the mammalian host. Alternating between 
the two organisms, the parasite not only adapts its 
energy metabolism to the respective environment 
but also its cell surface protein coat, which is a 
crucial determinant of the parasite’s virulence. 
Apart from being a deadly pathogen affecting the 
socio-economic development in endemic areas, the 
parasite has emerged as an interesting model 
organism for basic research. Two proliferative 
stages of T. brucei, bloodstream trypomastigotes 
(bloodstream form parasites) and the insect-stage 
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procyclic trypomastigotes (procyclic form 
parasites) can easily be cultured in vitro. 
Biological features such as trans-splicing (1), 
RNA editing (2), and antigenic variation (3) were 
first described in Trypanosomatids and only later 
also found in other eukaryotes. In addition, 
T. brucei was one of the first organisms in which 
glycosylphosphatidylinositol (GPI)8-anchoring of 
cell surface proteins was described and extensively 
explored (4, 5). Protein-linked GPI anchors consist 
of the conserved core structure ethanolamine-
HPO4-Manα1-2Manα1-6Manα1-4GlcNα1-6-
myo-inositol phospholipid with the amino group of 
ethanolamine linked to the C-terminus of the 
protein (4, 5).	   A wide variety of linear and 
branched glycosyl substituents and additional 
ethanolamine phosphate moieties can be attached 
to this core, depending on the protein to which the 
anchor is attached and the organism in which it is 
synthesized. The best-studied and most abundant 
GPI-anchored proteins of T. brucei are the variant 
surface glycoproteins (VSGs) in bloodstream form 
parasites (6) and the procyclins in procyclic 
forms (7–9). Whereas the VSG GPI core is 
modified by rather simple galactosyl side 
chains (5), the GPI anchors of procyclins are the 
largest and most complex anchors known, 
comprising large branched N-acetyllactosamine 
(Galβ1-4GlcNAc) and lacto-N-biose (Galβ1-
3GlcNAc)-containing side chains often capped 
with α2-3-linked sialic acid residues (10, 11). 
Based on their C-terminal amino acid sequences 
containing di- or pentapeptide tandem repeats, 
procyclins are divided into two classes: EP (rich in 
Glu-Pro repeats) and GPEET (rich in Gly-Pro-
Glu-Glu-Thr repeats) procyclins (11). Two of the 
three subclasses of EP procyclins, EP1 and EP3, 
contain a single N-glycosylation site (11, 12), 
whereas EP2 and GPEET procyclins are not 
N-glycosylated. Interestingly, EP1 and EP3 
procyclins are modified exclusively by a 
triantennary Man5GlcNAc2 moiety (11), 
transferred to protein by oligosaccharyltransferase 
TbSTT3B, which is expressed in procyclic 
forms (13) and specifically uses mature 
Man9GlcNAc2-PP-dolichol (mDLO) for transfer to 
N-glycosylation sites (14). Due to the lack of a 
Golgi α-mannosidase in procyclic form 
trypanosomes, Man9GlcNAc2 glycans can only be 
trimmed to triantennary Man5-GlcNAc2 that are 
not further modified (15). Figure 1A shows a 
schematic representation of a typical N-
glycosylated EP procyclin. 
RFT1 was first described in S. cerevisiae 
as a protein “requiring fifty-three”, i.e. human p53, 
in a screen of mutants that could be rescued by 
heterologous expression of p53 (16). Only later, 
yeast RFT1 (Rft1p) was found to play an essential 
role in protein N-glycosylation (17). The multi-
pass transmembrane protein was reported to be 
localized in the endoplasmic reticulum (ER) of 
yeast and human cells (17, 18), though no 
corresponding localization data have been 
published. The accumulation of the dolichol-
linked oligomannose intermediate Man5GlcNAc2-
PP-dolichol (M5-DLO) in S. cerevisiae cells 
depleted of Rft1p but having intact 
O-glycosylation and GPI anchoring suggested that 
RFT1 is a flippase enabling translocation of 
M5-DLO across the ER membrane (17). However, 
this interpretation was challenged by subsequent 
biochemical studies, where flipping of M5-DLO 
was assayed in vitro using proteoliposomes 
containing Triton X-100 extracted yeast ER 
membrane proteins (19, 20). Flipping of M5-DLO 
occurred robustly in the absence of Rft1p, e.g., 
when proteoliposomes were reconstituted with 
fractionated ER-membrane proteins, M5-DLO 
translocation activity was found in fractions 
devoid of Rft1p (19). Similar experiments using 
sealed microsomes confirmed these findings (21). 
Hence, it was postulated that S. cerevisiae Rft1p 
has only an indirect involvement in the 
translocation of M5-DLO (19–21). 
More recently, the role of RFT1 was 
revisited using T. brucei as model organism. By 
complementation of yeast lacking RFT1 function, 
T. brucei RFT1 (TbRFT1; Tb927.11.11670) was 
shown to represent a functional homolog of 
S. cerevisiae Rft1p (22). TbRFT1-null procyclic 
trypanosomes grew nearly normally, had normal 
steady-state levels of mDLO and reduced but still 
significant N-glycosylation, indicating robust 
M5-DLO flippase activity. Nevertheless, TbRFT1-
null parasites had 30–100-fold greater steady state 
levels of M5-DLO compared to wild-type 
trypanosomes. Fluorophore-assisted carbohydrate 
electrophoresis analysis of N-glycans released 
from N-linked glycoproteins showed that all N-
glycans in the TbRFT1-null cells originate from 
mDLO, indicating that the M5-DLO excess is not 
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used for glycosylation. Together these results 
suggested that rather than facilitating M5-DLO 
flipping, RFT1 appears to promote conversion of 
M5-DLO to mDLO by another mechanism, 
possibly by acting as an M5-DLO chaperone (22). 
We now report that the lack of TbRFT1 in 
T. brucei procyclic forms not only affects N-
glycosylation but also GPI anchor glycosylation. 
In addition, we unexpectedly localize TbRFT1 to 
both the ER and Golgi. These results suggest that 
RFT1 has a pleiotropic influence on protein 
glycosylation. 
RESULTS AND DISCUSSION 
Procyclins of TbRFT1 null cells exhibit 
reduced apparent molecular masses — Based 
on our previous observation that the lysosomal 
marker protein p67 is underglycosylated in 
TbRFT1 null mutants (22), we investigated if a 
similar glycosylation phenotype could also be 
observed for the major surface coat protein of T. 
brucei procyclic forms, EP procyclin. EP 
procyclins are encoded by three different genes, 
EP1-3, with EP1 and EP3 proteins each containing 
a single N-glycosylation site, whereas EP2 and the 
other subclass of procyclin, GPEET, are not N-
glycosylated (11, 23, 24). The relative abundance 
of EP1-3 and GPEET varies among trypanosome 
strains and culture conditions (11, 12, 25) and 
during tsetse infection	  (26, 27). In the strain used 
in this study, T. brucei Lister 427, GPEET 
represents the predominant surface protein, but EP 
is also expressed (25). Analysis by SDS-PAGE 
and immunoblotting revealed a smaller apparent 
molecular mass of EP in TbRFT1 null cells 
compared to wild-type (WT) trypanosomes (Fig. 
1B). Treatment of EP from WT cells with protein 
N-glycosidase F (PNGase) to release protein N-
glycans (see Fig. 1A) reduced its apparent 
molecular mass. However, the apparent size of de-
N-glycosylated EP from WT trypanosomes was 
larger than that of EP from TbRFT1 null cells, 
which was unaffected by PNGase treatment (Fig. 
1B). Together, these results indicate that the 
altered molecular mass of EP is not only due to 
altered N-glycosylation in TbRFT1 null parasites 
but involves other modifications caused by lack of 
TbRFT1. 
TbRFT1 null procyclins have truncated 
GPI anchor side-chains — Since all EP isoforms, 
as well as GPEET, are GPI-anchored (23, 28), we 
hypothesized that decreased glycosylation of the 
GPI anchor side-chain may contribute to the 
observed phenotype. The procyclin GPI anchors 
are modified by a large heterogeneous, branched 
side chain comprising poly-N-acetyllactosamine 
and lacto-N-biose units that may be capped with 
sialic acid residues (10, 11) (Fig. 1A). Partial or 
complete loss of this glycan moiety would lead to 
reduced apparent molecular masses of GPEET and 
EP. Hence, we analyzed the procyclin GPI anchors 
by in vivo labeling of trypanosomes with 
[3H]ethanolamine ([3H]Etn), which gets 
incorporated into the GPI core structure (23, 25). 
SDS-PAGE and fluorography showed that 
GPEET, migrating with an apparent molecular 
mass of 22 – 29 kDa, was readily labeled with 
[3H]Etn in WT trypanosomes (Fig. 1C). Labeling 
of GPEET was also observed in TbRFT1 null 
parasites, however, the protein migrated with a 
lower molecular mass compared to WT 
trypanosomes (Fig. 1C). To eliminate molecular 
mass differences present in the protein part of 
GPEET, extracts were treated with pronase, which 
has been shown to digest the entire protein portion 
of GPEET down to the C-terminal glycine 
residue (25). The resulting GPI anchor was again 
analyzed by SDS-PAGE and fluorography and 
showed a clear difference in molecular mass 
between WT and TbRFT1 null parasites (Fig. 1C). 
To confirm that the GPEET polypeptide 
itself is not truncated in TbRFT1 null parasites, its 
mass was analyzed by MALDI-TOF-MS after 
sequential treatment with aqueous hydrofluoric 
acid (to remove the GPI anchor, leaving 
ethanolamine attached to the C-terminal amino 
acid; see Fig. 1A) and mild trifluoroacetic acid (to 
cleave Asp-Pro bonds within the EP sequence; see 
Fig. 1A) (12). The results in Fig. 2A/B show that 
both WT and ΔTbrft1 cells express the same 
GPEET fragments GP-4 and GP-13 representing 
proteins lacking 4 and 13, respectively, N-terminal 
amino acids. Furthermore, the masses are 
consistent with the presence of ethanolamine 
linked to Gly, further corroborating that ΔTbrft1 
cells are not defective in the transfer of GPIs to 
proteins. In addition, a series of EP procyclin C-
terminal fragments were also detected. 
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To determine the degree of GPI 
underglycosylation in ΔTbrft1 cells, n-butanol 
extracts (rich in procyclins) were analyzed by gas 
chromatography-mass spectrometry (GC-MS). As 
expected, while the WT sample yielded a 
composition of Man : Gal : GlcNAc : sialic acids 
(SA) of 1.0 : 1.4 : 0.4 : 0.2, ΔTbrft1 cells showed a 
~7-fold reduction in the overall GPI sugar content, 
resulting in a ratio of Man : Gal : GlcNAc : SA of 
1.0 : 0.2 : 0.1 : ~0 (SA were not detectable). A 
similar reduction in the overall sugar composition 
of another ΔTbrft1 mutant (i.e. B1 cells (22)) was 
also observed by GC-MS (not shown). 
Collectively, these results show that trypanosomes 
lacking TbRFT1 express procyclins with truncated 
GPI anchor side-chains containing fewer poly-N-
acetyllactosamine/lacto-N-biose repeats and sialic 
acids, thus explaining the observed reductions in 
apparent molecular masses after SDS-PAGE. 
Procyclin GPI anchor size is restored by 
ectopically expressed TbRFT1 — To study if the 
observed differences in EP and GPEET molecular 
masses between WT and TbRFT1 null mutants are 
indeed due to the lack of TbRFT1, we generated 
add-back mutants by expressing HA-tagged or 
untagged copies of TbRFT1 in the ΔTbrft1 
background. If functional, these ectopically 
expressed proteins are expected to restore the 
molecular masses of EP and GPEET to wild-type 
sizes. Immunoblotting using antibodies against the 
HA-epitope demonstrated that RFT1-HA was 
expressed in the respective clones (Fig. 3A). In 
addition, the results showed that in TbRFT1 null 
parasites expressing HA-TbRFT1 or untagged 
TbRFT1 the apparent molecular mass of EP was 
comparable to wild-type EP procyclin (Fig. 3B), 
indicating that both tagged and untagged TbRFT1 
are functional and restored EP glycosylation as 
well as GPI glycan maturation. A similar result 
was obtained by analyzing [3H]Etn-labeled EP and 
GPEET using SDS-PAGE and fluorography 
(Fig. 3C). 
GPI precursor synthesis and in vitro 
GPI galactosylation are TbRFT1-independent 
— To study if the lack of TbRFT1 affects the 
formation of PP1, the GPI precursor added to 
protein in the ER (29), trypanosomes were 
cultured in the presence of [3H]Etn, which 
becomes incorporated into all ethanolamine-
capped GPI precursors. Analysis of extracts from 
WT, TbRFT1 null and TbRFT1 addback parasites 
by thin layer chromatography (TLC) revealed that 
PP1 was the major [3H]Etn-labeled lipid 
irrespective of the presence or absence of TbRFT1 
(Fig. 4A). 
Assembly of the GPI core structure and 
attachment to protein occurs in the ER (30–32). At 
present, it is unclear whether the glycan 
modification at the central mannose residue starts 
before or after GPI attachment to protein in the 
ER, or on protein-bound GPI anchors in the Golgi. 
It is known that galactose is added in vitro to GPI 
anchor precursors in bloodstream form 
T. brucei (33), suggesting the presence of ER-
resident galactosyltransferases that are able to act 
on GPI precursors. To date, only two T. brucei 
glycosyltransferases involved in GPI processing 
are known: GT8 and GT3. However both seem to 
localize to the Golgi, with GT8 mediating the 
transfer of the first GlcNAc-moiety to the terminal 
digalactose moiety of the immature GPI 
anchor (34, 35) and GT3 attaching a galactose 
residue to GlcNAc	  (36). To study if decreased 
galactosylation in the ER may cause 
underglycosylation of the GPI anchors in TbRFT1 
null cells, we pulse-labeled crude membrane 
preparations from TbRFT1 add-back and TbRFT1 
null parasites with [3H]GDP-Man in the presence 
of UDP-GlcNAc and chased the labeled GPI 
precursors with non-radiolabeled GDP-Man and 
UDP-Gal. Tunicamycin was added to the assays to 
inhibit formation of the N-glycan precursor Dol-
PP-GlcNAc. TLC analysis of [3H]-labeled GPI 
lipids after extraction with chloroform/methanol/ 
water followed by n-butanol-water partitioning 
showed that additional more polar species were 
formed during the chase with UDP-Gal (Fig. 4B, 
green arrows). However, we observed no 
differences in the galactosylation pattern between 
wild type and TbRFT1 null cells, indicating that 
galactosylation of GPI precursors in the ER is not 
affected by lack of TbRFT1. 
The ER lumenal mannose donor dolichol-
phosphate mannose (Dol-P-Man) is one of the 
most prominent radiolabeled lipid species after 
pulse-labeling membranes with [3H]GDP-Man 
(Fig. 4B). As expected, Dol-P-Man as well as the 
early GPI intermediate Man1-GlcN-PI almost 
completely disappeared during the chase. 
Interestingly, extracts from both pulse- and chase-
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labeled ΔTbrft1 membranes contained additional 
polar mannose-containing lipids (Fig. 4B, blue 
arrows). A comparison with extracts from 
membranes labeled in the absence of tunicamycin 
(Fig. 4C) shows that compounds with similar Rf 
values are formed also by WT membranes as long 
as N-glycan synthesis is enabled. Treatment of the 
labeled lipids with mild acid led to degradation of 
Dol-P-Man as well as the unknown polar species 
from both wild-type and mutant extracts (Fig. 4C 
and D). Conversely, the acid-sensitive lipids were 
not cleaved by GPI-specific phospholipase D, 
whereas the known GPI intermediates were readily 
hydrolyzed (Fig. 4D). Together, these results 
suggest that the unknown species made by mutant 
membranes are tunicamycin-insensitive dolichol-
linked oligomannose species that most likely 
originate from a pool of preformed (early) 
intermediates. We conclude that side-chain 
glycosylation of newly synthesized GPI precursors 
occurs normally in ΔTbrft1 membranes. 
Possible roles of TbRft1 in GPI anchor 
modification — The defects in GPI anchor 
maturation of TbRFT1 null cells can be interpreted 
in two ways. TbRFT1 may have a direct role in 
GPI anchor glycan modification that is 
independent of its function in N-glycosylation. 
Alternatively, the defect may result from 
incomplete N-glycosylation of a 
glycosyltransferase involved in GPI anchor 
modification, leading to decreased activity and 
thus incomplete glycan modification.  
First, we considered the possibility that the 
appearance of truncated GPI anchors may be 
caused by a glycosylation defect occurring in the 
Golgi. To study if TbRFT1 is present exclusively 
in the ER, as suggested for yeast (17), we analyzed 
the localization of the functional HA-tagged copy 
of TbRFT1 in the TbRFT1 null background using 
immunofluorescence microscopy. Co-staining of 
TbRFT1-HA with an antibody against the ER 
lumenal chaperone BiP confirmed the expected 
localization of TbRFT1 in the ER, where it was 
predominantly found in the perinuclear region 
(Fig. 5A). Interestingly, however, co-staining of 
TbRFT1-HA with an antibody against the Golgi 
resident protein TbGRASP (37) also showed co-
localization (Fig. 5A). In >70% of parasites 
examined (n>100), TbRFT1-HA co-stained with a 
spot located between the nucleus and the 
kinetoplast and representing the Golgi. To exclude 
the possibility that the observed co-localization of 
TbRFT1 with TbGRASP is unspecific, we 
analyzed the localization of an HA-tagged 
membrane-bound member of the EMC family of 
proteins, TbEMC3 (Tb927.10.4760), which has 
been shown in yeast to localize to the ER (38). 
The results showed <35% co-localization of 
TbEMC3-HA with TbGRASP (Fig. 5B). Although 
we cannot completely exclude the possibility that 
a portion of TbRFT1 is localized to the Golgi as a 
result of saturation of the retention system for ER 
membrane proteins, we consider it unlikely for the 
following reasons: i) TbRFT1-HA shows a similar 
dual localization when expressed by a different, 
tetracycline-inducible, expression vector in 
T  brucei 427 wild-type cells (Fig. 5C), ii) over-
expression of another ER-localized membrane 
protein, TbEPT, using the same tetracycline-
inducible vector showed no Golgi localization and 
was specifically targeted to the perinuclear ER 
(39), and iii) there is no precedent in trypanosomes 
for mislocalization of ER proteins on over-
expression of a single ER resident. Dual 
localization of trypanosome proteins in both the 
ER and Golgi is not unique to TbRFT1 but has 
been reported before (40). In contrast, no co-
localization was observed between TbRFT1-HA 
and cathepsin L, a marker for the T. brucei 
lysosome (41) that also localizes between the 
nucleus and the kinetoplast (Fig. 5D). The role of 
TbRFT1 in glycosylation in the Golgi remains 
speculative. In a recent publication, RNAi-
mediated silencing of the nucleotide sugar 
transporter TbNST4 responsible for import of 
UDP-GlcNAc, GDP-mannose and UDP-GalNAc 
into the Golgi resulted in production of 
underglycosylated EP procyclin in T. brucei 
procyclic forms (42). In addition, defective forms 
of GT3 (36) or GT8 (35, 43) resulted in impaired 
GPI glycan maturation and reduced protein N-
glycosylation. It is possible that a lack of TbRFT1 
affects Golgi resident proteins involved in 
glycosylation, by directly interacting with these 
proteins or affecting their glycosylation status. 
To study the second possibility, we 
analyzed GPEET procyclin in cells grown in the 
presence of tunicamycin during 10 days to inhibit 
N-linked glycosylation. The results show that the 
molecular mass of GPEET was reduced by 
tunicamycin treatment to that of GPEET in 
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ΔTbrft1 cells (Fig. 6A). Binding of FITC-labeled 
Concanavalin A to parasites followed by analysis 
by fluorescence-activated cell sorting (FACS) 
demonstrated that tunicamycin effectively 
inhibited N-glycosylation (Fig. 6B). 
Concluding remarks — We report 
several new findings that implicate RFT1 in a 
wider range of glycosylation processes than 
previously demonstrated. Procyclic form 
trypanosomes lacking TbRFT1 not only have 
decreased protein N-glycosylation but also 
produce underglycosylated GPI anchors. The 
defect is not associated with the synthesis of the 
anchor but with GPI processing/maturation steps 
that likely occur in the Golgi apparatus. A role for 
TbRFT1 in the Golgi would be consistent with our 
observation that TbRFT1-HA is dually localized in 
the ER and Golgi. Our observations open new 
questions regarding the enigmatic function of 
TbRFT1 and its orthologs in yeast and mammalian 
cells. 
EXPERIMENTAL PROCEDURES 
Materials — Unless otherwise stated, all 
reagents were of analytical grade and purchased 
from Sigma Aldrich (Buchs, Switzerland) or 
Merck (Darmstadt, Germany). Restriction 
enzymes were from Fermentas (St. Leon-Rot, 
Germany) and antibiotics from Sigma Aldrich, 
Invivogen (Nunningen, Switzerland) or Invitrogen 
(Basel, Switzerland). [1-3H]ethanolamine 
hydrochloride (40-60 Ci/mmol) ([3H]Etn) and 
[3H]GDP-mannose ([3H]GDP-Man) were from 
American Radiolabeled Chemicals Inc. (St. Louis, 
MO). BioMax MS and MXBE films were from 
GE Healthcare (Buckinghamshire, UK) or 
Carestream Health (Rochester, NY, USA). 
Trypanosome cultures — T. brucei strain 
Lister 427 procyclic forms were cultured at 27 °C 
in SDM-79 containing 5% heat-inactivated fetal 
bovine serum. TbRFT1 knock-out trypanosomes 
(ΔTbrft1, TbRFT1 null) (22) were grown under the 
same condition, but in the presence of 1 µg/ml 
G418 for the single allele knock-out and an 
additional 10 µg/ml blasticidin for the double 
allele knock-out clones. TbRFT1 addback mutants 
in ΔTbrft1 double allele knock-out cells were 
selected and grown in the same medium, with an 
additional 2 µg/ml puromycin. T. brucei strain 
Lister 427 29-13 (TetR T7RNAP) procyclic forms 
for tetracycline-inducible gene expression were 
cultured at 27 °C in SDM-79 containing 10% heat-
inactivated fetal bovine serum, 25 µg/ml 
hygromycin, and 15 µg/ml G418. 
Generation of T. brucei RFT1 addback 
procyclic forms — The generation of the T. 
brucei strain Lister 427 procyclic form TbRFT1 
null cell line ΔTbrft1::NEO/ΔTbrft1::BLAST has 
been described previously (22). For the generation 
of procyclic trypanosomes constitutively 
expressing TbRFT1 or 2x hemagglutinin (HA)-
tagged TbRFT1 (TbRFT1-HA) in the ΔTbrft1 
background (ΔTbrft1/RFT1 and ΔTbrft1/RFT1-
HA), the ORF of TbRFT1 (Tb927.11.11670) was 
PCR-amplified with primers TbRFT1β_fwd 
(tgtagcaagcttgaattcatggacttcaaacgacagctg) and 
TbRFT1β_rev (ccccgcagatctctactcgccgcttctttttga) 
or TbRFT1_fwd and TbRFTβ-HA rev (ccccgcagat
ctctatgcatagtctggtacgtcataagggtatgcatagtctggtacgtc
ataagggtatgcatagtctggtacgtcataagggtactcgagctcgcc
gcttctttttgagct), respectively, and ligated into 
vector pG-EGFPΔLII β (44) (kindly provided by 
Isabel Roditi, University of Bern, Bern, 
Switzerland), previously digested with HindIII and 
BglII. The resulting vectors pG-RFT1ΔLII β and 
pG-RFT1-HAΔLII β were digested with NotI prior 
to transfection into ΔTbrft1 cells. Clones were 
obtained by limiting dilution under antibiotic 
selection using 2 µg/ml puromycin. For the 
expression of tetracycline-inducible TbRFT1-HA 
the gene was PCR-amplified using primers 
TbRFT1-
HA_fwd (tgtagcgggcccatggacttcaaacgacagctg) and 
TbRFT1-HA_rev 
(cctcatgcatctagactcgccgcttctttttgagct), digested 
with ApeI and XbaI and ligated into equally 
digested vector pALC14-HA (original vector 
pALC14 kindly provided by André Schneider, 
University of Bern, Bern, Switzerland), containing 
a 3x HA-tag downstream of the C-terminal 
restriction site. The resulting vector pALC14-
TbRFT1-HA was linearized with NotI prior to 
transfection into T. brucei, strain Lister 427 29-13 
procyclic forms. Clones were obtained by limiting 
dilution under antibiotic selection using 2 µg/ml 
puromycin. 
Immunofluorescence microscopy of 
trypanosomes — 2 x 106 cells were harvested at 
mid-log phase, washed twice in cold phosphate-
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buffered saline (PBS; 137 mM NaCl2, 2.7 mM 
KCl, 10 mM Na2PO4, 2 mM KH2PO4, pH 7.4) and 
spotted on microscope slides. After adherence, 
cells were fixed with 4% paraformaldehyde in 
PBS for 5 min, washed with cold PBS, and 
permeabilized with 0.2% (w/v) Triton X-100 in 
PBS for 5 min. Subsequently, cells were blocked 
with 2% (w/v) bovine serum albumin in PBS prior 
to incubation with blocking solution containing 
primary antibodies [mouse monoclonal anti-HA 
11, 16B12 (1:200; Enzo Life Sciences; cat nr. 
ENZ-ABS118-0500, lot 04211508), rabbit 
polyclonal anti-BiP (1:2500) and rabbit polyclonal 
anti-cathepsin L (1:500) (both kindly provided by 
J. Bangs, University of Buffalo, Buffalo, NY), 
rabbit polyclonal anti-TbGRASP (1:1500; kindly 
provided by G. Warren, Vienna Biocenter, Vienna, 
Austria)]. Fluorescent secondary antibodies with 
different excitation and emission maxima were 
used to visualize TbRFT1-HA separately from 
BiP, TbGRASP, and cathepsin L, respectively 
[Alexa Fluor® goat anti-mouse 488 (Invitrogen™, 
cat. nr. A11001, lot 1170048) and goat anti-rabbit 
594 (Invitrogen™, cat. nr. A11005, lot 1750828), 
diluted 1:1000 in blocking solution]. Coverslips 
were mounted on dried slides with Vectashield® 
containing 4’,6-diamidino-2-phenylindole (DAPI, 
Vector Laboratories) to visualize the nuclei. 
Pictures were taken with a Leica DM 16000 B 
inverted microscope combined with a Leica 
DFC360 FX camera. Image deconvolution (3D 
deconvolution) and further processing were 
performed using Leica LAS X software and 
ImageJ (NIH), respectively. 
[3H]Etn-labeling of GPI precursors and 
GPI-anchored proteins — For in vivo 
radiolabeling of procyclins, procyclic form 
trypanosomes were cultured in the presence of 
[3H]Etn (2 µCi/ml) during 16 h to a density of 
approximately 1.5 x 107 cells/ml, as described 
before (25). Cells were counted, harvested by 
centrifugation and washed twice in cold Tris-
buffered saline (TBS; 10 mM Tris-HCl pH 7.5, 
144 mM NaCl). Bulk lipids from up to 2.5 x 108 
cells were extracted from the cell pellets using 2 x 
10 ml chloroform/methanol (2:1, v/v) and GPI 
precursors and free GPIs were extracted using 3 x 
5 ml of chloroform/methanol/water (10:10:3, 
v/v/v)(25). GPI-anchored proteins were extracted 
from the remaining protein pellet using 2 x 1 ml 
9% (v/v) butan-1-ol in water during 2 h on ice, 
followed by 10 min of centrifugation at 17000 x g. 
The resulting supernatants were pooled, dried 
under a stream of nitrogen and dissolved in 
electrophoresis sample buffer containing 2.5% 
(w/v) SDS. Butan-1-ol-insoluble material was 
further extracted with 0.1% (w/v) Triton X-100 in 
20 mM Tris (pH 7.4) for 10 min at 95 °C(25). 
Radioactivity in the butan-1-ol and Triton X-100 
extracts was determined by liquid scintillation 
counting of small aliquots. For the analysis of 
[3H]Etn-labeled GPI precursors all cultures were 
adjusted to 1.5 x 107 cells/ml prior to incubation 
with 4 µCi/ml [3H]Etn during 4 h. After washing 
with TBS and extraction of bulk lipids using 2 x 
10 ml chloroform/methanol (2:1, v/v), GPI 
precursors were extracted by 3 x 5 ml of 
chloroform/methanol/water (10:10:3, v/v/v). The 
resulting supernatants were pooled, dried under a 
stream of nitrogen and partitioned between 0.5 ml, 
each, of butan-1-ol and water. After a second 
extraction of the resulting water phase with 0.5 ml 
of water-saturated butan-1-ol, butanol phases were 
pooled and dried using a speed-vac apparatus. Dry 
GPI lipids were resuspended in 50 µl 
chloroform/methanol/water (10:10:3, v/v/v) and 
separated by TLC as described below. 
Protein analysis — Proteins from butan-
1-ol and Triton X-100 extracts were separated by 
SDS-PAGE using 12% polyacrylamide gels. 
[3H]Etn-labeled proteins were analyzed by soaking 
the fixed gel in AmplifyTM for 1 hour, drying at 
80 °C for 2 h and exposing to MXBE film 
at -70 °C. HA-tagged TbRFT1, EP and GPEET 
procyclins were analyzed by immunoblotting onto 
polyvinylidene difluoride membranes and 
enhanced chemiluminescence using mouse anti-
HA antibody (HA11, diluted 1:3000 in TBS 
containing 5% skimmed milk powder; Enzo Life 
Sciences), mouse anti-EP antibody (mouse 
monoclonal anti-EP 247, diluted 1:1000 in 
TBS/5% milk; Cedarlane, Canada; cat.nr. 
CLP001A, lot P115) and mouse anti-GPEET 5H3 
antibody (diluted 1:5000 in TBS/5% milk; lot 
991109 (45)), respectively, followed by HRP-
conjugated anti-mouse IgG (diluted 1:5000 in 
TBS/5% milk; Dako, Switzerland). MXBE films 
were exposed to ECL-activated membranes 
(SuperSignal West Pico, Pierce-ThermoFisher, 
Switzerland) for 30 seconds to a few minutes. 
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Mass spectrometry analysis — For the 
analysis of procyclin C-terminal polypeptides, 
total procyclins were purified by sequential 
extraction with CMW (10:10:3, by vol.) and 9% 
(v/v) butan-1-ol as described above.  Butan-1-ol 
extracts were then dried, dephosphorylated with 
48% anhydrous hydrofluoric acid for 24 h at 0 °C, 
hydrolyzed with mild (40 mM) trifluoroacetic 
acid, and then analyzed by negative-ion MALDI-
TOF on an ABI Voyager DESTR instrument using 
sinapinic acid as the matrix (12). To determine the 
total monosaccharide composition of procyclins, 
samples were mixed with 200 pmol of scyllo-
inositol (as internal standard) and analyzed by GC-
MS as described elsewhere (46). 
Enzyme treatments — PNGase: parasites 
were lysed by boiling 10 min at 100 °C in 
denaturing buffer (0.5% SDS, 40 mM DTT) and 
incubated with peptide-N-glycosidase F (PNGase, 
New England Biolabs) according to the 
manufacturer’s instructions in a buffer containing 
1% NP-40 during 1 h at 37 °C. Pronase: [3H]-
labeled GPI extracts were dried under a stream of 
nitrogen, re-dissolved in a buffer containing 
20 mM Tris (pH 7.5) and 5 mM CaCl2 and 
incubated with pronase (0.3 mg/ml) during 16 h at 
37 °C. 
Cell-free GPI glycosylation analysis — 
Membranes for cell-free labeling of GPI 
precursors were collected from trypanosome 
cultures grown to a density of 107 cells/ml by 
hypotonic lysis in water containing 0.1 mM Tosyl-
L-lysyl-chloromethane hydrochloride (TLCK) and 
1.25 µg/ml leupeptin. Pulse-chase radiolabeling of 
GPI precursors with [3H]GDP-Man was performed 
essentially according to the protocol developed by 
Masterson et al. (1989) (47) as described by Leal 
et al. (2004) (48). If indicated, experiments were 
performed in presence of 0.4 mg/ml tunicamycin 
in the assay buffer to inhibit the formation of 
dolichol-linked N-glycan precursors. In pulse-
chase experiments, membranes from 1.5 x 108 
cells were labeled with 3 µCi [3H]GDP-Man and 
1 mM UDP-GlcNAc for 8 min at 37 °C, followed 
by a 75 min chase with 2 mM non-radioactive 
GDP-Man. For the analysis of GPI 
galactosylation, 8 mM UDP-Gal was added during 
the chase with GDP-Man. GPI lipids were 
extracted as described (47). Butan-1-ol extracts 
were separated by thin layer chromatography 
(TLC) on silica gel 60 plates (Merck Millipore, 
Darmstadt, Germany) using chloroform/methanol/ 
water (10:10:3, v/v/v) as solvent system and 
analyzed using a radioactivity TLC scanner 
(Berthold Technologies, Regensburg, 
Switzerland). For autoradiography, TLC plates 
were treated with EN3HANCE™ spray (Perkin 
Elmer, Waltham, MA, USA) prior to exposure to 
film at -70 °C. 
Flow cytometry — Trypanosomes were 
grown in the presence or absence of tunicamycin 
(1 µg/ml) during 10 days. Approximately 1x107 
parasites were harvested by centrifugation at 4 °C 
for 10 min at 1500 x g in 15 ml centrifuge tubes, 
washed twice in ice-cold SDM-79 and 
resuspended in 200 µl of SDM-79 containing 
0.5 mM MnCl2. Concanavalin A-FITC conjugate 
was added to a final concentration of 1.5 µg/ml. 
After 1 hour of incubation in the dark on ice, the 
cells were diluted with ice-cold PBS to a volume 
of 5ml, pelleted, resuspended in a final volume of 
2 ml (final concentration 5 x 106/ml PBS) and 
passed through a cell-filter cap prior to analysis by 
FACSCalibur (BD). Data were analyzed using 
flow cytometry software FlowJo. 
 
 
ACKNOWLEDGEMENTS 
We thank Luce Farine for generating a T. brucei procyclic form cell line expressing TbEMC3-HA 
and Jennifer Jelk and Monika Rauch for excellent technical assistance during parts of the study. We also 
thank the Dundee University Proteomics Facility and Mike Ferguson for generous use of the MALDI 
Voyager and GC-MS, respectively, and Aitor Casas-Sánchez for the tunicamycin protocol. P.B. thanks 
William White for stimulation. The work was supported by grants from the Swiss National Science 
Foundation to P.B. (Sinergia CRSII3_141913 and 149353), NIH grant R21NS093457 to A.K.M. and 
GlycoPar-EU FP7 Marie Curie Initial Training Network (GA. 608295) to A.A-S. 
 
 at LIV
ERPO
O
L SCH
O
O
L O
F TRO
PICA
L M
ED
ICIN
E on D
ecem
ber 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
RFT1 and GPI anchor glycosylation 
9	  
	  
CONFLICT OF INTEREST 
The authors declare that they have no conflicts of interest with the contents of this article. 
 
AUTHOR CONTRIBUTIONS 
PG designed, performed, and analyzed the experiments shown in Figs 1C, 3–6 and prepared all 
figures. AGS generated RFT1 addback-strains and performed the experiment shown in Fig. 1B. YCL and 
AAS developed the protocol for in vitro galactosylation of GPI precursors. AAS designed the scheme in 
Fig. 1A, and designed and performed mass spectrometry analyses presented in Fig. 2. PB conceived and 
coordinated the study, PB and PG wrote the paper. AAS and AKM provided scientific and experimental 
advice and critically revised the paper.  
 
REFERENCES 
1.  Sutton, R. E., and Boothroyd, J. C. (1986) Evidence for Trans splicing in trypanosomes. Cell. 47, 
527–535 
2.  Blum, B., Bakalara, N., and Simpson, L. (1990) A model for RNA editing in kinetoplastid 
mitochondria: RNA molecules transcribed from maxicircle DNA provide the edited information. 
Cell. 60, 189–198 
3.  Cross, G. A. (1977) Antigenic variation in trypanosomes. Am. J. Trop. Med. Hyg. 26, 240–4 
4.  Ferguson, M. A., Homans, S. W., Dwek, R. A., and Rademacher, T. W. (1988) Glycosyl-
phosphatidylinositol moiety that anchors Trypanosoma brucei variant surface glycoprotein to the 
membrane. Science. 239, 753–9 
5.  Ferguson, M. A. J. (1999) The structure, biosynthesis and functions of 
glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J. Cell Sci. 
112, 2799–2809 
6.  Allen, G., Gurnett, L. P., and Cross, G. A. M. (1982) Complete amino acid sequence of a variant 
surface glycoprotein (VSG 117) from Trypanosoma brucei. J. Mol. Biol. 157, 527–546 
7.  Roditi, I., Carrington, M., and Turner, M. (1987) Expression of a polypeptide containing a 
dipeptide repeat is confined to the insect stage of Trypanosoma brucei. Nature. 325, 272–274 
8.  Mowatt, M. R., and Clayton, C. E. (1988) Polymorphism in the procyclic acidic repetitive protein 
gene family of Trypanosoma brucei. Mol. Cell. Biol. 8, 4055–62 
9.  Roditi, I., Schwarz, H., Pearson, T. W., Beecroft, R. P., Liu, M. K., Richardson, J. P., Buhring, H.-
J., Pleiss, J., Bulow, R., Williams, R. O., and Overath, P. (1989) Procycline gene expression and 
loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. J. Cell Biol. 
108, 737–746 
10.  Ferguson, M. A. J., Murray, P., Rutherford, H., and McConville, M. J. (1993) A simple 
purification of procyclic acidic repetitive protein and demonstration of a sialylated glycosyl-
phosphatidylinositol membrane anchor. Biochem. J. 291, 51–55 
11.  Treumann, A., Zitzmann, N., Hülsmeier, A., Prescott, A., Almond, A., Sheehan, J., and Ferugson, 
M. A. J. (1997) Structural Characterisation of Two Forms of Procyclic Acidic Repetitive Protein 
Expressed by Procyclic Forms of Trypanosoma brucei. J. Mol. Biol. 1, 529–547 
 at LIV
ERPO
O
L SCH
O
O
L O
F TRO
PICA
L M
ED
ICIN
E on D
ecem
ber 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
RFT1 and GPI anchor glycosylation 
10	  
	  
12.  Acosta-Serrano, A., Cole, R. N., Mehlert, A., Lee, M. G.-S., Ferguson, M. A. J., and Englund, P. 
T. (1999) The Procyclin Repertoire of Trypanosoma brucei: Identification and Structural 
Characterization of the GLU-PRO-rich Polypeptides. J. Biol. Chem. 274, 29763–29771 
13.  Izquierdo, L., Mehlert, A., and Ferguson, M. A. J. (2012) The lipid-linked oligosaccharide donor 
specificities of Trypanosoma brucei oligosaccharyltransferases. Glycobiology. 22, 696–703 
14.  Acosta-Serrano, A., O’Rear, J., Quellhorst, G., Lee, S. H., Hwa, K.-Y., Krag, S. S., and Englund, 
P. T. (2004) Defects in the N-Linked Oligosaccharide Biosynthetic Pathway in a Trypanosoma 
brucei Glycosylation Mutant. Eukaryot. Cell. 3, 255–263 
15.  Manthri, S., Güther, M. L. S., Izquierdo, L., Acosta-Serrano, A., and Ferguson, M. A. J. (2008) 
Deletion of the TbALG3 gene demonstrates site-specific N-glycosylation and N-glycan processing 
in Trypanosoma brucei. Glycobiology. 18, 367–83 
16.  Koerte, A., Chong, T., Li, X., Wahane, K., and Cai, M. (1995) Suppression of the Yeast Mutation 
rft1-1 by Human p53. J. Biol. Chem. 270, 22556–22564 
17.  Helenius, J., Ng, D. T. W., Marolda, C. L., Walter, P., Valvano, M. A., and Aebi, M. (2002) 
Translocation of lipid-linked oligosaccharides across the ER membrane requires Rft1 protein. 
Nature. 415, 447–50 
18.  Haeuptle, M. A. (2008) Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation. 
Am. J. Hum. Genet. 82, 600–606 
19.  Sanyal, S., Frank, C. G., and Menon, A. K. (2008) Distinct Flippases Translocate 
Glycerophospholipids and Oligosaccharide Diphosphate Dolichols across the Endoplasmic 
Reticulum †. Biochemistry. 47, 7937–7946 
20.  Frank, C. G., Sanyal, S., Rush, J. S., Waechter, C. J., and Menon, A. K. (2008) Does Rft1 flip an 
N-glycan lipid precursor? Nature. 454, E3-NaN-E5 
21.  Rush, J. S., Gao, N., Lehrman, M. A., Matveev, S., and Waechter, C. J. (2009) Suppression of 
Rft1 expression does not impair the transbilayer movement of Man5GlcNAc2-P-P-dolichol in 
sealed microsomes from yeast. J. Biol. Chem. 284, 19835–42 
22.  Jelk, J., Gao, N., Serricchio, M., Signorell, A., Schmidt, R. S., Bangs, J. D., Acosta-Serrano, A., 
Lehrman, M. A., Bütikofer, P., and Menon, A. K. (2013) Glycoprotein biosynthesis in a eukaryote 
lacking the membrane protein Rft1. J. Biol. Chem. 288, 20616–23 
23.  Clayton, C. E., and Mowatt, M. R. (1989) The procyclic acidic repetitive proteins of Trypanosoma 
brucei. Purification and post-translational modification. J. Biol. Chem. 264, 15088–15093 
24.  Hwa, K.-Y., Acosta-Serrano, A., Khoo, K.-H., Pearson, T., and Englund, P. T. (1999) Protein 
glycosylation mutants of procyclic Trypanosoma brucei: defects in the asparagine-glycosylation 
pathway. Glycobiology. 9, 125–131 
25.  Bütikofer, P., Ruepp, S., Boschung, M., and Roditi, I. (1997) “GPEET” procyclin is the major 
surface protein of procyclic culture forms of Trypanosoma brucei brucei strain 427. Biochem. J. 
326, 415–23 
26.  Vassella, E., Van Den Abbeele, J., Bütikofer, P., Renggli, C. K., Furger, A., Brun, R., and Roditi, 
I. (2000) A major surface glycoprotein of Trypanosoma brucei is expressed transiently during 
development and can be regulated post-transcriptionally by glycerol or hypoxia. Genes Dev. 14, 
615–626 
27.  Acosta-Serrano, A., Vassella, E., Liniger, M., Renggli, C. K., Brun, R., Roditi, I., and Englund, P. 
 at LIV
ERPO
O
L SCH
O
O
L O
F TRO
PICA
L M
ED
ICIN
E on D
ecem
ber 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
RFT1 and GPI anchor glycosylation 
11	  
	  
T. (2001) The surface coat of procyclic Trypanosoma brucei: Programmed expression and 
proteolytic cleavage of procyclin in the tsetse fly. Proc. Natl. Acad. Sci. 98, 1513–1518 
28.  Ferguson, M., Low, M., and Cross, G. (1985) Glycosyl-sn-1,2-dimyristylphosphatidylinositol is 
covalently linked to Trypanosoma brucei variant surface glycoprotein. J. Biol. Chem. 260, 14547–
14555 
29.  Field, M. C., Menon, A. K., and Cross, G. A. (1991) A glycosylphosphatidylinositol protein 
anchor from procyclic stage Trypanosoma brucei: lipid structure and biosynthesis. EMBO J. 10, 
2731–9 
30.  Orlean, P., and Menon, A. K. (2007) Thematic review series: Lipid Posttranslational 
Modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop 
worrying and love glycophospholipids. J. Lipid Res. 48, 993–1011 
31.  Sanyal, S., and Menon, A. K. (2009) Flipping lipids: why an’ what’s the reason for? ACS Chem. 
Biol. 4, 895–909 
32.  Hong, Y., and Kinoshita, T. (2009) Trypanosome glycosylphosphatidylinositol biosynthesis. 
Korean J. Parasitol. 47, 197–204 
33.  Mayor, S., Menon, A. K., and Cross, G. A. M. (1992) Galactose-containing 
Glycosylphosphatidylinositols in Trypanosoma brucei. 267, 754–761 
34.  Izquierdo, L., Nakanishi, M., Mehlert, A., Machray, G., Barton, G. J., and Ferguson, M. A. J. 
(2009) Identification of a glycosylphosphatidylinositol anchor-modifying beta1-3 N-
acetylglucosaminyl transferase in Trypanosoma brucei. Mol. Microbiol. 71, 478–91 
35.  Nakanishi, M., Karasudani, M., Shiraishi, T., Hashida, K., Hino, M., Ferguson, M. A. J., and 
Nomoto, H. (2014) TbGT8 is a bifunctional glycosyltransferase that elaborates N-linked glycans 
on a protein phosphatase AcP115 and a GPI-anchor modifying glycan in Trypanosoma brucei. 
Parasitol. Int. 63, 513–8 
36.  Izquierdo, L., Acosta-Serrano, A., Mehlert, A., and Ferguson, M. A. (2015) Identification of a 
glycosylphosphatidylinositol anchor-modifying β1-3 galactosyltransferase in Trypanosoma brucei. 
Glycobiology. 25, 438–47 
37.  He, C. Y., Ho, H. H., Malsam, J., Chalouni, C., West, C. M., Ullu, E., Toomre, D., and Warren, G. 
(2004) Golgi duplication in Trypanosoma brucei. J. Cell Biol. 165, 313–21 
38.  Lahiri, S., Chao, J. T., Tavassoli, S., Wong, A. K. O., Choudhary, V., Young, B. P., Loewen, C. J. 
R., and Prinz, W. A. (2014) A Conserved Endoplasmic Reticulum Membrane Protein Complex 
(EMC) Facilitates Phospholipid Transfer from the ER to Mitochondria. PLoS Biol. 12, e1001969 
39.  Farine, L., Niemann, M., Schneider, A., and Bütikofer, P. (2015) Phosphatidylethanolamine and 
phosphatidylcholine biosynthesis by the Kennedy pathway occurs at different sites in 
Trypanosoma brucei. Sci. Rep. 5, 16787 
40.  Martin, K. L., and Smith, T. K. (2006) Phosphatidylinositol synthesis is essential in bloodstream 
form Trypanosoma brucei. Biochem. J. 396, 287–295 
41.  Mbawa, Z. R., Gumm, I. D., Shaw, E., and Lonsdale-Eccles, J. D. (1992) Characterisation of a 
cysteine protease from bloodstream forms of Trypanosoma congolense. Eur. J. Biochem. 204, 
371–379 
42.  Liu, L., Xu, Y.-X., Caradonna, K. L., Kruzel, E. K., Burleigh, B. A., Bangs, J. D., and Hirschberg, 
C. B. (2013) Inhibition of nucleotide sugar transport in Trypanosoma brucei alters surface 
 at LIV
ERPO
O
L SCH
O
O
L O
F TRO
PICA
L M
ED
ICIN
E on D
ecem
ber 19, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
RFT1 and GPI anchor glycosylation 
12	  
	  
glycosylation. J. Biol. Chem. 288, 10599–615 
43.  Izquierdo, L., Schulz, B. L., Rodrigues, J. A., Güther, M. L. S., Procter, J. B., Barton, G. J., Aebi, 
M., and Ferguson, M. A. J. (2009) Distinct donor and acceptor specificities of Trypanosoma 
brucei oligosaccharyltransferases. EMBO J. 28, 2650–61 
44.  Furger, A., Schürch, N., Kurath, U., and Roditi, I. (1997) Elements in the 3’ untranslated region of 
procyclin mRNA regulate expression in insect forms of Trypanosoma brucei by modulating RNA 
stability and translation. Mol. Cell. Biol. 17, 4372–80 
45.  Bütikofer, P., Vassella, E., Ruepp, S., Boschung, M., Civenni, G., Seebeck, T., Hemphill,  a, 
Mookherjee, N., Pearson, T. W., and Roditi, I. (1999) Phosphorylation of a major GPI-anchored 
surface protein of Trypanosoma brucei during transport to the plasma membrane. J. Cell Sci. 112 ( 
Pt 1, 1785–1795 
46.  Ferguson, M. A. J. (1993) Glycobiology: A Practical Approach (Fukuda, M., and Kobata, A. eds), 
Oxford University Press, Oxford 
47.  Masterson, W. J., Doering, T. L., Hart, G. W., and Englund, P. T. (1989) A novel pathway for 
glycan assembly: Biosynthesis of the glycosyl-phosphatidylinositol anchor of the trypanosome 
variant surface glycoprotein. Cell. 56, 793–800 
48.  Leal, S., Acosta-Serrano, A., Morris, J., and Cross, G. A. M. (2004) Transposon mutagenesis of 
Trypanosoma brucei identifies glycosylation mutants resistant to concanavalin A. J. Biol. Chem. 
279, 28979–88 
49.  Hall, B. S., Pal, A., Goulding, D., Acosta-Serrano, A., and Field, M. C. (2005) Trypanosoma 
brucei: TbRAB4 regulates membrane recycling and expression of surface proteins in procyclic 
forms. Exp. Parasitol. 111, 160–171 
50.  Field, M. C., Menon, A. K., and Cross, G. A. M. (1991) Developmental Variation of 
Glycosylphosphatidylinositol Membrane Anchors in Trypanosoma brucei. J Biol Chem. 266, 
8392–8400 
 
FOOTNOTES 
8The abbreviations used are: GPI, glycosylphosphatidylinositol; VSG, variant surface glycoprotein; 
mDLO, Man9GlcNAc2-PP-dolichol; M5-DLO, Man5GlcNAc2-PP-dolichol; PNGase, protein N-
glycosidase F; Etn, ethanolamine; Man, mannose, Gal, galactose; GlcNAc, N-acetyl-glucosamine; SA, 
sialic acid; Dol-P-Man, dolichol-phosphate mannose. 
 
FIGURE LEGENDS 
Figure 1: Schematic representation of procyclin glycosylation and analysis of GPI-anchored 
proteins in TbRFT1 null cells. A) Most procyclin isoforms (except EP2 and GPEET) are modified by a 
homogeneous triantennary Man5GlcNAc2 glycan near the N-terminus. The GPI anchor of all procyclins is 
modified with several N-acetyllactosamine or lacto-N-biose repeats, which may be capped with sialic 
acids depending on the presence of blood sialoglycoconjugates. These repeats are linked to the middle 
mannose of the GPI anchor core via two consecutive galactose residues (dotted box), which are probably 
added in the ER as suggested in Fig. 2. The C-terminal regions of EP procyclins consist of 22 – 30 Glu-
Pro repeats. Schematic diagram based on Izquierdo et al 2009 (34). B) Immunoblot analysis of EP 
procyclins isolated from wild-type (WT) and TbRFT1 null (Δrft1) cells. Denatured proteins were treated 
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with (+) or without (–) PNGase F to remove N-glycans and separated by SDS-PAGE. After 
electrotransfer to membranes, EP was visualized by enhanced chemiluminescence using anti-EP antibody 
and HRP-conjugated anti-mouse IgG. C) [3H]ethanolamine labeling and fluorography of GPI-anchored 
proteins from wild-type (WT) and TbRFT1 null (Δrft1) cells. Trypanosomes were grown in the presence 
of [3H]ethanolamine and GPI-anchored proteins were extracted from the delipidated protein pellet using 
9% butan-1-ol. Extracts incubated in the absence (–) or presence (+) of pronase to remove the protein 
portions of GPEET and EP were separated by SDS-PAGE and analyzed by fluorography. 
Figure 2: Negative-ion MALDI-TOF-MS analysis of procyclins after removal of the GPI anchors. 
Butan-1-ol extracts from wild-type (WT) (panel A) and Δrft1 (panel B) cells were subjected to 48% 
aqueous hydrofluoric acid dephosphorylation followed by mild trifluoroacetic acid hydrolysis to remove 
the GPI anchor and generate EP procyclin peptides. The resulting polypeptides, corresponding to the C-
terminal portions of procyclins, were analyzed by negative-ion MALDI-TOF-MS. GP(-4) and (-13) refer 
to GPEET fragments lacking 4 and 13, respectively, amino acids at the N-terminus. EP isoforms EP1-1 
(I) (P(EP)nG-Etn) and II (PDP(EP)nG-Etn) represent C-terminal mild acid fragments (12). EP3-5 is an 
unusual form containing 21 EP repeats (49). 
Figure 3: Ectopic expression of TbRFT1 and TbRFT1-HA. EP from wild-type (WT), TbRFT1 null 
cells (Δrft1), and TbRFT1 null cells expressing a HA-tagged (+) or untagged (-) ectopic copy of TbRFT1 
(Δrft1/RFT1) were analyzed by SDS-PAGE and immunoblotting. Enhanced chemiluminescence was used 
to visualize HA (panel A) or EP (panel B) using corresponding first and secondary antibodies. C) EP and 
GPEET in WT, TbRFT1 null cells (Δrft1), and TbRFT1 null cells expressing a HA-tagged (+) or 
untagged (-) ectopic copy of TbRFT1 (Δrft1/RFT1) were labeled with [3H]ethanolamine, extracted and 
analyzed as described in the legend to Fig. 1. The sizes of wild type (solid lines) and mutant (dashed 
lines) proteins are marked (blue: EP, green: GPEET). 
Figure 4: Analysis of GPI precursor formation. A) Analysis of in vivo [3H]Etn-labeled GPI precursors 
PP3 and PP1 extracted from wild-type (WT), TbRFT1 knockout (Δrft1) and addback (Δrft1/RFT1) cells. 
Trypanosome densities were adjusted before addition of [3H]Etn to the cultures. After 4 h of labeling, GPI 
precursors were extracted, separated by TLC and visualized using a radioactivity TLC scanner. The 
migration of PP1, PP3 (50) and phosphatidylethanolamine (PE) is indicated. B-D) In vitro [3H]GDP-
mannose (GDP-Man) labeling of GPI precursors. B) Membranes from hypotonically lysed TbRFT1 
knockout (Δrft1) and addback (Δrft1/RFT1) cells were pulse-labeled (p) with [3H]GDP-Man, followed by 
a chase (c) with non-radioactive GDP-Man in presence (+) or absence of (-) UDP-galactose. [3H]-labeled 
glycolipids were extracted, separated by TLC, and visualized by fluorography. Galactosylated GPI 
intermediates are indicated with green arrows. Blue arrows indicate the additional [3H]GDP-mannose 
containing species formed in Δrft1 extracts. C) Analysis of [3H]-labeled glycolipids from wild-type and 
Δrft1 after a 30 min labeling with [3H]GDP-Man in presence (+) or absence (–) of tunicamycin (Tu) 
(lanes 1-4). Lanes 5 and 6 show aliquots labeled in absence of tunicamycin that were treated with 0.1 M 
HCl before TLC. D) Biochemical analysis of [3H]-labeled glycolipids from Δrft1 and Δrft1/RFT1 after a 
30 min labeling with [3H]GDP-Man in presence (+) of tunicamycin. Primary lipid extracts were split and 
treated with GPI-specific phospholipase D (GPI-PLD) or 0.1 M HCl as indicated. Lipids were re-
extracted after treatment and separated by TLC along with an aliquot of untreated primary extract. 
Figure 5: Localization of TbRFT1 in procyclic form parasites. A) Functional TbRFT1-HA was co-
stained with the ER marker protein BIP (upper panels) or the Golgi marker TbGRASP (lower panels). 
The merged channels (composite) show overlap (yellow color) of the BIP and TbRFT1-HA signals 
mainly in the perinuclear zone, with some weaker signal distributed throughout the rest of the cells. Co-
staining with the Golgi marker TbGRASP shows that the brightest spots of the HA signal co-localize with 
the Golgi signal. Some areas were zoomed for better visibility (panels on the right). B) Trypanosomes 
expressing TbEMC3-HA were co-stained with TbGRASP (upper panels). The merged channels 
(composite) show little overlap (yellow color) of the signals. Golgi-stained areas were zoomed for better 
visibility (panels on the right). The lower panels show co-staining of TbRFT1-HA with TbGRASP done 
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in parallel with the staining shown in the upper panels. Again, TbRFT1 co-localized with TbGRASP. 
DNA was stained with DAPI (blue). C) Co-staining of TbRFT1-HA with the Golgi marker TbGRASP in 
cells transiently expressing TbRFT1-HA under the control of a tetracycline operator. Tetracycline 
(1 µg/ml)	  was added to the growth medium for 20 hours prior to preparation of slides. D) Functional 
TbRFT1-HA was co-stained with the lysosomal marker protein cathepsin L (CatL) and DAPI as 
indicated. The composite shows little overlap (yellow color) of the signals. CatL-stained areas were 
zoomed for better visibility (panels on the right). 
Figure 6: Tunicamycin-mediated inhibition of N-glycosylation in vivo. Cells were grown in the 
presence (+) or absence (-) of 1 µg/ml tunicamycin (Tu) during 10 days. A) Proteins extracted from 2 x 
107 cells were separated by SDS PAGE, and GPEET procyclin was detected by immunoblotting using 
anti-GPEET antibody 5H3. B) Cell surface N-glycosylation levels were assessed by lectin-binding and 
flow cytometry using FITC-conjugated concanavalin A. The shift in cell surface fluorescence intensity 
reflects inhibition of N-glycosylation by tunicamycin. 
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FIGURES 
Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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